Exploring mutation specific beta blocker pharmacology of the pathogenic late sodium channel current from patient-specific pluripotent stem cell myocytes derived from long QT syndrome mutation carriers

Comollo, T. W., Zou, X., Zhang, C., Kesters, D., Hof, T., Sampson, K. J., & Kass, R. S. (2022). Exploring mutation specific beta blocker pharmacology of the pathogenic late sodium channel current from patient-specific pluripotent stem cell myocytes derived from long QT syndrome mutation carriers. Channels, 16(1), 173–184. https://doi.org/10.1080/19336950.2022.2106025
Authors:
Thomas W Comollo
Xinle Zou
Chuangeng Zhang
Divya Kesters
Thomas Hof
Kevin J Sampson
Robert S Kass
Affiliated Authors:
Thomas W Comollo
Xinle Zou
Chuangeng Zhang
Divya Kesters
Thomas Hof
Kevin J Sampson
Robert S Kass
Columbia Affiliation:
Subjects:
Long QT Syndrome (MeSH)
Pluripotent Stem Cells (MeSH)
Author Keywords:
long qt syndrome
propranolol
induced pluripotent stems
elink
Publication Type:
Article
Unique ID:
10.1080/19336950.2022.2106025
PMID:
35949058
DOI:
10.1080/19336950.2022.2106025
Journal:
Channels
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record

Record Created: